Standard Venofer (Iron Sucrose) Dosing
The standard dosing for Venofer is 200 mg administered intravenously over 10-15 minutes as a single dose, with a maximum weekly dose of 500 mg, though typical administration uses 100 mg per dose to minimize adverse effects. 1, 2
FDA-Approved Administration Routes
Venofer contains 20 mg of elemental iron per mL and is available in 100 mg (5 mL) and 200 mg (10 mL) single-dose vials. 2, 3
Two administration methods are approved:
- Slow IV push (undiluted): 100 mg administered over 2-5 minutes 2
- IV infusion (diluted): Up to 200 mg diluted in normal saline, administered over 15 minutes (FDA) or 30 minutes (European Medicines Agency) 1, 2
Maximum Dosing Parameters
Critical dosing limits to prevent adverse effects:
- Maximum single dose: 200 mg 1, 2
- Maximum weekly dose: 500 mg 1, 2
- For doses of 300-500 mg: Must be diluted in maximum 250 mL of 0.9% NaCl 4
Optimal Dosing Strategy
The 100 mg per dose regimen is preferred in clinical practice because it minimizes dose-related adverse effects including arthralgias, myalgias, hypotension, and flushing, which are rare at doses ≤100 mg but increase with higher doses. 1, 2
Practical dosing approach:
- Administer 100 mg once or twice weekly until iron deficiency is corrected 1, 2
- Total cumulative dose typically 1000 mg for most patients 1, 5
- Monitor hemoglobin, ferritin, and transferrin saturation to assess response 2
Population-Specific Considerations
Chronic Kidney Disease patients (hemodialysis):
- 100 mg per dialysis session (typically 3 times weekly) is standard 1
- Doses >100 mg increase risk of arthralgias/myalgias 1
Non-dialysis CKD and predialysis patients:
- 200 mg weekly for 5 doses (total 1000 mg) is effective 6
- Can be combined with low-dose erythropoietin for faster correction 6
Cancer patients:
- Total doses in range of 1000 mg iron administered in divided doses 1
- Maximum single dose remains 200 mg 1
Safety Monitoring Requirements
Mandatory precautions during administration:
- Resuscitation facilities must be immediately available, as anaphylaxis may occur with any IV iron preparation 1, 4, 3
- Monitor vital signs during and for at least 30 minutes after infusion until clinically stable 4, 3
- Test doses are NOT required for iron sucrose, unlike iron dextran, but consider in patients with history of sensitivities to IV iron or multiple drug allergies 4
Management of minor infusion reactions:
- Stop infusion and switch to hydration fluid 4
- Monitor for 15 minutes; most reactions are self-limiting 4
- May rechallenge after 15 minutes with careful monitoring 4
- If symptoms persist or worsen, administer IV hydrocortisone 4
Common Pitfalls to Avoid
Do not exceed 200 mg single dose - higher doses significantly increase risk of dose-related adverse effects including arthralgias, myalgias, and hypotension. 1, 2
Avoid administration in patients with active infection - defer IV iron therapy until infection is controlled. 4
Monitor for hypotension - particularly when co-administered with ACE inhibitors, which increases risk of abdominal cramps and hypotension. 2
Do not administer to patients with iron overload - regularly monitor hematologic parameters and ferritin levels to prevent excessive iron accumulation. 3
Free iron may occur if 100 mg is administered when transferrin levels are <180 mg/dL - check transferrin saturation before dosing. 2